Oragenics, Inc. OGEN
Nov 10, 2026, 11:50 AM EST
- YTD
- -53.21%
- 1 year
- -67.41%
Discussion (173)
Sign in to join the discussion
$ACST going to take off soon ???????
$OGEN selling now ?????
Selling time starts ????
$OGEN going down much faster than expected ?
$OGEN Selling here
Great news everyone ?????
10:49a ET 1/7/2021 - Benzinga
Why Oragenics Inc. Common Stock's Stock is Up During Today's Session
Mentioned: OGEN
The Price And Volume Action In Oragenics Inc. Common Stock's Stock Today
Oragenics Inc. Common Stock's (AMEX:OGEN) stock is trading up 37.41% to a price of $0.9. The stock's current volume for the day is 139.84 million, which is approximately 770.47% of its previous 30-day average volume of 18.15 million.
Why It's Moving
Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Oragenics shares are trading higher after the company entered into a material transfer agreement with Adjuvance Technologies for COVID-19 vaccine adjuvant.
Perspective On Recent Price Action
The 50-day moving average price of Oragenics Inc. Common Stock's stock was $0.47 when this article was published. The stock reached a high of $2.09 and a low of $0.36 in the past 52 weeks.
If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get â??Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
lol you guys were all crying in the 80s and now a couple cents later... bbboooommmm! Gtfoh
Last opportunity to load below .9...its going parabolic ???
9:32a ET 1/7/2021 - Benzinga
*Oragenics shares are trading higher after the company entered into a material transfer agreement with Adjuvance Technologies for COVID-19 vaccine adjuvant.
Mentioned: OGEN
everyone should buy now great news
9:32a ET 1/7/2021 - Benzinga
*Oragenics shares are trading higher after the company entered into a material transfer agreement with Adjuvance Technologies for COVID-19 vaccine adjuvant.
Mentioned: OGEN